Stay updated with breaking news from String Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN--(BUSINESS WIRE)--The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Circulating Tumor…
The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East Africa)
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Vir Biotechnology (NASDAQ:VIR – Get Rating) and NanoString Technologies (NASDAQ:NSTG – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk & Volatility Vir Biotechnology has a beta of -0.97, […]
NanoString Technologies (NASDAQ:NSTG – Get Rating) had its price objective dropped by Robert W. Baird from $51.00 to $35.00 in a report released on Wednesday, The Fly reports. Robert W. Baird’s target price points to a potential upside of 58.30% from the company’s current price. A number of other brokerages also recently issued reports on […]